HMOX1 and prostate carcinoma: In this regard, we also observed increased levels of NRF2 and HO-1 upon SFN treatment in both untransformed human T-cells (Supplementary Figure 5A) and prostate cancer PC-3 cells (Supplementary Figure 5B).